Skip to content
AwardedUnited KingdomServices

Framework for the Provision of Parenteral Systemic Anti-Cancer Therapies and Other Biologicals Including Immunotherapies

Published
Published 7 May 2025
Deadline
Closed 11 October 2024

Overview

This Framework agreement is for the provision of Parenteral Systemic Anti-Cancer Therapies and Other Biologicals Including Immunotherapies initially for patients of East Midlands Pharmacy Collaborative (EMPC) Member Trusts referred to henceforth as the 'Service' to Participating Purchasing Authorities

Key details

Country
United Kingdom
Status
Awarded
Category
Services
Procedure
Open
SME suitable
Yes
Published
7 May 2025
Deadline
Closed
Classification (CPV)
Health services

Award outcome

Awarded value
£2,760,000
Award date
29 April 2025
Contract period
30 April 2025 → 30 April 2027
Winners
  • Alcura Healthcare Ltd.
  • B. Braun Medical Limited
  • HealthNet Homecare (UK) Limited
  • LloydsPharmacy Clinical Homecare
  • Pharmaxo Pharmacy Services Ltd
  • Sciensus Pharma Services Limited

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    7 May 2025

Contracting authority

  • East Midlands Pharmacy Collaborative

    Buyer

    Derby, United Kingdom

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Framework for the Provision of Parenteral Systemic Anti-Cancer Therapies and Other Biologicals Including Immunotherapies — won by Alcura Healthcare Ltd. +5 — Skim